Efficacy and Safety Of Infliximab Or Adalimumab Vs Abatacept In Patients With Rheumatoid Arthritis and An Inadequate Response To Methotrexate: Attest-Ample Network Randomized Trial

被引：0
|
作者：
Christensen, Robin [1 ,2 ]
Tarp, Simon [1 ,2 ]
Furst, Daniel E. [3 ]
Kristensen, Lars E. [4 ]
Bliddal, Henning [1 ,2 ]
机构：
[1] Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Musculoskeletal Stat Unit, Bispebjerg, Denmark
[2] Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Musculoskeletal Stat Unit, Frederiksberg, Denmark
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Lund Univ, Rheumatol Sect, Dept Clin Sci, Lund, Sweden
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
499
引用
收藏
页码：S219 / S219
页数：1
相关论文
共 50 条
  • [1] The efficacy and safety of abatacept or infliximab in patients with rheumatoid arthritis and an inadequate response to methotrexate
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Becker, J. C.
    Li, T.
    Schiff, M.
    RHEUMATOLOGY, 2008, 47 : II14 - II15
  • [2] Safety and efficacy of abatacept over 4 years of treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate in the AIM trial
    Kremer, J. M.
    Russell, A. S.
    Emery, P.
    Abud-Mendoza, C.
    Szechinski, J.
    Zhao, C.
    Becker, J-C
    Westhovens, R.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S308 - S309
  • [3] Safety and Efficacy of Abatacept Over 4 Years of Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate in the AIM Trial
    Russell, A. S.
    Kremer, J. M.
    Emery, P.
    Abud-Mendoza, C.
    Szechinski, J.
    Zhao, C.
    Becker, J-C
    Westhovens, R.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2608 - 2609
  • [4] Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
    Schiff, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Li, T.
    Aranda, R.
    Becker, J-C
    Lin, C.
    Cornet, P. L. N.
    Dougados, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (08) : 1096 - 1103
  • [5] Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis
    Charles-Schoeman, C.
    Gugiu, G. B.
    Ge, H.
    Shahbazian, A.
    Lee, Y. Y.
    Wang, X.
    Furst, D. E.
    Ranganath, V. K.
    Maldonado, M.
    Lee, Terry
    Reddy, S. T.
    ATHEROSCLEROSIS, 2018, 275 : 107 - 114
  • [6] CLINICAL EFFICACY OF ABATACEPT AND INFLIXIMAB IN COMBINATION WITH METHOTREXATE ACCORDING TO BASELINE RHEUMATOID FACTOR STATUS IN THE ATTEST TRIAL
    Dougados, Maxime
    Gaillez, Corine
    Le Bars, Manuela
    Poncet, Coralie
    Elegbe, Ayanbola
    Schiff, Michael
    RHEUMATOLOGY, 2012, 51 : 127 - 127
  • [7] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VS ADALIMUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: KEY EFFICACY AND SAFETY RESULTS FROM THE AMPLE TRIAL
    Weinblatt, Michael E.
    Schiff, Michael H.
    Fleischmann, Roy
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    Maldonado, Michael A.
    RHEUMATOLOGY, 2013, 52 : 45 - 46
  • [8] Time to treatment response with abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate
    Kremer, J. M.
    Westhovens, R.
    Le Bars, M.
    Lafosse, C.
    Gaillez, C.
    Koncz, T.
    Schmidely, N.
    Dougados, M.
    Schiff, M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S308 - S308
  • [9] Efficacy of abatacept or infliximab treatment in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a 1-year double-blind, randomized, placebo-controlled trial
    Bessette, L.
    Homik, J.
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Aranda, R.
    Becker, J.
    Li, T.
    Lin, C.
    Cornet, P. L. N.
    Schiff, M.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1178 - 1179
  • [10] Efficacy of abatacept or infliximab treatment in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a 1-year double-blind, randomized, placebo-controlled trial
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Aranda, R.
    Becker, J.
    Li, T.
    Lin, C.
    Cornet, R. L. N.
    Schiff, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 88 - 88
12345